{"id":"W2883682996","doi":"10.21037/atm.2018.06.13","title":"Skin cancer management—updates on Merkel cell carcinoma","year":2018,"lang":"en","type":"review","venue":"Annals of Translational Medicine","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Merkel cell carcinoma; Avelumab; Pembrolizumab; Merkel cell; Skin cancer; Medicine; Ipilimumab; Nivolumab; Radiation therapy; Clinical trial; Oncology; Adjuvant; Basal cell carcinoma; Dermatology; Internal medicine; Cancer; Basal cell; Immunotherapy; Carcinoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004561048,0.000527614,0.0008819993,0.002357647,0.0003014966,0.0007489374,0.0006557041,0.0009283667,0.005026508],"category_scores_gemma":[0.001091492,0.000208265,0.0006399067,0.001423762,0.000327594,0.001288869,0.0005199961,0.001624472,0.001510102],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000474659,"about_ca_system_score_gemma":0.0008396711,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001327502,"about_ca_topic_score_gemma":0.003081227,"domain_scores_codex":[0.9997929,0.00004301457,0.00004353656,0.00002908275,0.00007536172,0.00001616539],"domain_scores_gemma":[0.999504,0.0002369414,0.00006875682,0.00001254675,0.000144412,0.00003342731],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003385894,0.00004890953,0.0001908572,0.02034554,0.00007171329,0.0002422811,0.00007850135,0.000248232,0.0006197264,0.001967017,0.08453718,0.8916162],"study_design_scores_gemma":[0.00001020838,0.00003983201,0.0007512853,0.01168103,0.000103529,0.002479555,0.00007066013,0.00005541372,0.0001497958,0.001269674,0.9833757,0.00001326682],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001002489,0.9972851,0.00008752738,0.0007705058,0.0005247615,0.00000506112,0.00002534347,0.00000804516,0.001193319],"genre_scores_gemma":[0.0005985393,0.9976652,0.0001801768,0.0005193903,0.0004725654,0.000004064132,0.00004783654,0.000002001032,0.0005103392],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005026508,"threshold_uncertainty_score":0.01681536,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1429975010095433,"score_gpt":0.4272948209139789,"score_spread":0.2842973199044356,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}